Clinical Trials Browser

INDUSTRY × etirinotecan pegol × Other solid neoplasm × Clear all

NCT01457118 2021-07-12

An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies

Phase 2 Completed

27 enrolled 18 charts

Other solid neoplasm

Malignant Solid Tumor

NCT01976143 2016-12-22

A Study in Cancer Patients to Evaluate the Effect of a Single Dose of NKTR-102 (Etirinotecan Pegol) on the QTc Interval and to Assess Pharmacokinetics and Safety

Phase 1 Completed

Other solid neoplasm

Advanced Cancer